Evidence map›Paper›PMID 34888650›Full record

ArticleCarcinogenesis2022

Modulation of the oral glucocorticoid system during black raspberry mediated oral cancer chemoprevention.

Divya Nedungadi, Nathan Ryan, Kelvin Anderson, Felipe F Lamenza, Pete P Jordanides, Michael J Swingler, Liva Rakotondraibe, Kenneth M Riedl, Hans Iwenofu, Steve Oghumu

Open access · greenAbstract read
In one paragraph

Article in Carcinogenesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Raspberry protective role in inflammatory diseases: An overview.Iranian journal of basic medical sciences · 2026
    Review
  5. Review
  6. Article
  7. Chemopreventive Potential of Artemisinin andInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Berries vs. Disease: Revenge of the Phytochemicals.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Divya NedungadiDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Nathan RyanDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Kelvin AndersonDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Felipe F LamenzaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Pete P JordanidesDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Michael J SwinglerDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Liva RakotondraibeDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
Kenneth M RiedlDepartment of Food Science, Parker Food Science Building, The Ohio State University, Columbus, OH, USA.
Hans IwenofuDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Steve OghumuDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID 0000-0001-5177-0652
The Ohio State University Wexner Medical Center · USThe Ohio State University · US

Funding

Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black RaspberriesK01CA207599 · NCI · OHIO STATE UNIVERSITY · PI OGHUMU, STEVE ONYEKA · 2017 to 2021
$715k
Defining the role of the oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomesR56DE030093 · NIDCR · OHIO STATE UNIVERSITY · PI OGHUMU, STEVE ONYEKA · 2021 to 2021
$561k
American Cancer Society RSG-19-079-01-TBGNCI NIH HHS K01 CA207599NIDCR NIH HHS R56 DE030093
6 · The paper itself

Abstract

Recent reports suggest that glucocorticoids (GCs), which can be synthesized in the oral mucosa, play an important role in cancer development. Therefore, the objectives of this study were to characterize the role of the oral GC system in oral cancer, and determine the effect of black raspberry (BRB) administration on GC modulation during oral cancer chemoprevention. We determined the expression of GC enzymes in various oral cancer cell lines, and investigated the role of the GC inactivating enzyme HSD11B2 on CAL27 oral cancer cells using siRNA mediated knockdown approaches. Using two in vivo models of oral carcinogenesis with 4-nitroquinoline 1-oxide carcinogen on C57Bl/6 mice and F344 rats, we determined the effect of BRB on GC modulation during head and neck squamous cell carcinoma chemoprevention. Our results demonstrate that HSD11B2, which inactivates cortisol to cortisone, is downregulated during oral carcinogenesis in clinical and experimental models. Knockdown of HSD11B2 in oral cancer cells promotes cellular proliferation, invasion and expression of angiogenic biomarkers EGFR and VEGFA. An ethanol extract of BRB increased HSD11B2 expression on oral cancer cells. Dietary administration of 5% BRB increased Hsd11b2 gene and protein expression and reduced the active GC, corticosterone, in cancer-induced mouse tongues. Our results demonstrate that the oral GC system is modulated during oral carcinogenesis, and BRB administration upregulates Hsd11b2 during oral cancer chemoprevention. In conclusion, our findings challenge the use of synthetic GCs in head and neck cancer, and support the use of natural product alternatives that potentially modulate GC metabolism in a manner that supports oral cancer chemoprevention.

Indexed as

4-Nitroquinoline-1-oxideAnimalsCarcinogenesisCarcinogensCarcinoma, Squamous CellCell Line, TumorCell ProliferationChemopreventionDisease Models, AnimalFemaleGlucocorticoidsHead and Neck NeoplasmsMiceMice, Inbred C57BLMouth MucosaMouth Neoplasms4-Nitroquinoline-1-oxideCarcinogensGlucocorticoids

Identifiers

PMID34888650
PMCPMC8832455
OpenAlexW4200607653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.